Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.
Azzaroli F, Colecchia A, Lodato F, Trerè D, Bacchi Reggiani ML, Festi D, Prati GM, Accogli E, Casanova S, Derenzini M, Roda E, Mazzella G. Azzaroli F, et al. Among authors: bacchi reggiani ml. Aliment Pharmacol Ther. 2006 Jul 1;24(1):129-36. doi: 10.1111/j.1365-2036.2006.02955.x. Aliment Pharmacol Ther. 2006. PMID: 16803611 Free article.
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study.
Lodato F, Azzaroli F, Brillanti S, Colecchia A, Tamé MR, Montagnani M, Muratori R, Giovanelli S, Feletti V, Bacchi Reggiani ML, Roda E, Mazzella G. Lodato F, et al. Among authors: bacchi reggiani ml. J Viral Hepat. 2005 Sep;12(5):536-42. doi: 10.1111/j.1365-2893.2005.00638.x. J Viral Hepat. 2005. PMID: 16108771 Clinical Trial.
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals.
Ravaioli F, Conti F, Brillanti S, Andreone P, Mazzella G, Buonfiglioli F, Serio I, Verrucchi G, Bacchi Reggiani ML, Colli A, Marasco G, Colecchia A, Festi D. Ravaioli F, et al. Among authors: bacchi reggiani ml. Dig Liver Dis. 2018 Jun;50(6):573-579. doi: 10.1016/j.dld.2018.02.010. Epub 2018 Feb 27. Dig Liver Dis. 2018. PMID: 29567413
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation After Direct-Acting Antivirals in HCV Cirrhotic Patients.
Dajti E, Ravaioli F, Colecchia A, Marasco G, Bacchi Reggiani ML, Colli A, Alemanni LV, Tamè M, Andreone P, Brillanti S, Azzaroli F, Mazzella G, Festi D. Dajti E, et al. Among authors: bacchi reggiani ml. Ultraschall Med. 2022 Jun;43(3):280-288. doi: 10.1055/a-1205-0367. Epub 2020 Jul 16. Ultraschall Med. 2022. PMID: 32674184 English.
Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment.
Colecchia A, Scaioli E, Montrone L, Vestito A, Di Biase AR, Pieri M, D'Errico-Grigioni A, Bacchi-Reggiani ML, Ravaioli M, Grazi GL, Festi D. Colecchia A, et al. Among authors: bacchi reggiani ml. J Hepatol. 2011 Feb;54(2):300-5. doi: 10.1016/j.jhep.2010.06.037. Epub 2010 Sep 7. J Hepatol. 2011. PMID: 21056498
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis.
Colecchia A, Montrone L, Scaioli E, Bacchi-Reggiani ML, Colli A, Casazza G, Schiumerini R, Turco L, Di Biase AR, Mazzella G, Marzi L, Arena U, Pinzani M, Festi D. Colecchia A, et al. Among authors: bacchi reggiani ml. Gastroenterology. 2012 Sep;143(3):646-654. doi: 10.1053/j.gastro.2012.05.035. Epub 2012 May 27. Gastroenterology. 2012. PMID: 22643348
141 results